BIODESIX, INC. BDSX 深 滬
已收盤 07-25 16:00:00 美东时间
0.4461
+0.028
+6.80%
華盛通- 最 高0.4495
- 今 開0.42
- 成交量 154.61万股
- 最 低 0.41
- 昨 收 0.4177
- 總市值 6557.67万
- 52周最高 2.04
- 市盈率 靜 --
- 換手率 1.05%
- 52周最低 0.1718
- 委 比 48.85%
- 總股本 1.47亿
- 歷史最高 31.99
- 量 比 0.82
- 振 幅 9.46%
- 歷史最低 0.1718
- 每 手 1
- 風險率 0.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025
Biodesix, Inc. will release its second-quarter 2025 financial results on August 7, followed by a conference call and webcast at 4:30 p.m. ET. Listeners can register via the provided links, with a replay available later on the company’s investor website. Biodesix offers diagnostic tests and development services to improve patient outcomes and support biopharmaceutical research. Forward-looking statements in this release involve risks and uncertain...
07-24 10:00
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
Biodesix and APAPP collaborate to launch educational programs for healthcare providers on innovative diagnostic biomarkers, such as Nodify Lung® and IQLung® blood tests, to improve early detection and personalized treatment for lung cancer patients. The partnership aims to empower providers, especially in rural and resource-limited settings, to enhance patient care and outcomes.
06-10 10:17
Biodesix Has Been Granted European Patent Number EP3698144 Titled "COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER".
https://register.epo.org/application?number=EP18868355
06-07 04:08
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
05-22 01:06
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Ratings for Biodesix (NASDAQ:BDSX) were provided by 4 analysts in the past thre...
05-15 06:01
What to Expect from P3 Health Partners's Earnings
P3 Health Partners (NASDAQ:PIII) is set to give its latest quarterly earnings r...
05-15 05:02
Craig-Hallum Maintains Buy on Biodesix, Lowers Price Target to $1.5
Craig-Hallum analyst Bill Bonello maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $3 to $1.5.
05-15 01:45
